Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
HEPARIN SODIUM INJECTION, USP FRESENIUS KABI CANADA LTD Anticipated shortage 1000UNIT Updated Report 2022-10-02 170881
FENTANYL CITRATE INJECTION, USP FRESENIUS KABI CANADA LTD Anticipated shortage 50MCG Updated Report 2022-10-02 170878
BIVALIRUDIN FOR INJECTION FRESENIUS KABI CANADA LTD Anticipated shortage 250MG Updated Report 2022-10-02 170875
VORICONAZOLE FOR INJECTION FRESENIUS KABI CANADA LTD Actual shortage 200MG Updated Report 2022-10-02 154479
TOBRAMYCIN INJECTION FRESENIUS KABI CANADA LTD Actual shortage 40MG Updated Report 2022-10-02 164261
MIDAZOLAM INJECTION FRESENIUS KABI CANADA LTD Actual shortage 1MG Updated Report 2022-10-02 164282
MILRINONE LACTATE INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 1MG Updated Report 2022-10-02 167705
HYDROMORPHONE HYDROCHLORIDE INJECTION, USP FRESENIUS KABI CANADA LTD Resolved 2MG Updated Report 2022-10-02 168499
ROPIVACAINE HYDROCHLORIDE INJECTION, USP FRESENIUS KABI CANADA LTD Resolved 5MG Updated Report 2022-10-02 155808
PROTAMINE SULFATE INJECTION, USP FRESENIUS KABI CANADA LTD Resolved 10MG Updated Report 2022-10-02 156322
REMIFENTANIL HYDROCHLORIDE FOR INJECTION STERIMAX INC Resolved 1MG Updated Report 2022-10-02 153966
XYLOCAINE 2% WITH EPINEPHRINE 1:200000 ASPEN PHARMACARE CANADA INC. Actual shortage 0.005MG 20MG Updated Report 2022-10-02 166122
OXYTOCIN INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 10UNIT Updated Report 2022-10-02 167490
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP PFIZER CANADA ULC Actual shortage 149MG Updated Report 2022-10-02 170505
HYMENOPTERA VENOM PRODUCT-WHITE-FACED HORNET VENOM PROTEIN (550 MCG) JUBILANT HOLLISTERSTIER LLC Actual shortage 550MCG Updated Report 2022-10-02 164500
OXYTOCIN INJECTION USP PFIZER CANADA ULC Actual shortage 10UNIT Updated Report 2022-10-02 169271
CLIMARA 75 BAYER INC Actual shortage 75MCG Updated Report 2022-10-02 169780
DEXTROSE INJECTION USP PFIZER CANADA ULC Actual shortage 500MG Updated Report 2022-10-02 170619
TOVIAZ PFIZER CANADA ULC Resolved 8MG Updated Report 2022-10-01 158318
TEVA-PREGABALIN TEVA CANADA LIMITED Resolved 150MG Updated Report 2022-10-01 161970

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
MINT-LEVOFLOXACIN MINT PHARMACEUTICALS INC To be discontinued 750MG New Report 2022-10-02 170859
MINT-LEVOFLOXACIN MINT PHARMACEUTICALS INC To be discontinued 500MG New Report 2022-10-02 170856
MINT-LEVOFLOXACIN MINT PHARMACEUTICALS INC To be discontinued 250MG New Report 2022-10-02 170853
ROPIVACAINE HYDROCHLORIDE INJECTION USP PFIZER CANADA ULC Discontinued 5MG Updated Report 2022-10-02 170502
ROPIVACAINE HYDROCHLORIDE INJECTION USP PFIZER CANADA ULC Discontinued 10MG Updated Report 2022-10-02 170496